… The human antibodies studied in this paper were isolated from blood samples from two
individuals in North America with previous laboratory-confirmed symptomatic SARS-CoV-2 …

… To evaluate the protective efficacy of S2E12 and S2M11 against SARS-CoV-2 challenge
in vivo, we tested either mAb or a cocktail of both mAbs in a Syrian hamster model (44). The …

… species when administered before virus exposure; therefore, … clinical use as recombinant
monoclonal antibodies (mAbs) is being … of antibodies against SASR-CoV-2 and their protective …

… -2 recognize the spike (S) protein receptor-binding domain and block virus … of human
mAbs binding to diverse epitopes on the N-terminal domain (NTD) of S protein from SARS-CoV-2 …

… of T-cell responses and resulting protective immunity. It would be a public … antibody response,
after SARS-CoV-2 natural infection and vaccines may prove critically valuable if protective …

… -2, vaccine effectiveness, and duration of the humoral protective response, as well as
aiding … discusses the protective functions, possible protective mechanisms against SARS-CoV-2, …

… Identification of SARS-CoV-2-reactive antibodies in human sera collected prior to the COVID…
pre-pandemic SARS-CoV-2-reactive IgG antibodies in 431 human serum samples collected …

… antibody responses correlated with protective … antibodies can protect against challenge
with SARS-CoV-2 in macaques 15,16 . In the present study, we show that polyclonal antibodies …

… antibodies may contribute to the residual serum neutralizing activity against SARS-CoV-2 …
a broad, potent, and protective antibody, P36-5D2, isolated from a SARS-CoV-2 convalescent …

… on β-CoV spike proteins for protective antibodies that … SARS-CoV-2 spike protein stem helix
antibody, CC40.8, for binding to and neutralization of diverse sarbecoviruses and SARS-CoV…